It is morally reprehensible that the NEI was forced to act and create the CATT trial

Implications: I agree...the present situation is really quite absurd...in most practices...IF a third party is willing to pay for Lucentis...patients usually get Lucentis...if patients have to pay themselves...they usually receive Avastin...despite there not being a shred of convincing evidence that Lucentis is superior to Avastin...in fact...most retinal specialists suspect that Avastin might will be superior...due to a longer duration of effect...and thus requiring less frequent injections...It is morally reprehensible that the CATT trial is happening because the NEI had to step in...Genentech refused to do the right thing and compare their two medicines...instead...and even worse...they tried...last November...unsuccessfully...to block compounding pharmacies from supplying Avastin to retinal specialists...

Analysis: I agree...the present situation is really quite absurd...in most practices...IF a third party is willing to pay for Lucentis...patients usually get Lucentis...if patients have to pay themselves...they usually receive Avastin...despite there not being a shred of convincing evidence that Lucentis is superior to Avastin...in fact...most retinal specialists suspect that Avastin might will be superior...due to a longer duration of effect...and thus requiring less frequent injections...